Source: American journal of kidney diseases. Unidade: FM
Subjects: MUTAÇÃO GENÉTICA, CÁLCIO, NEFROPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOLDENSTEIN, Patricia T. e ONUCHIC, Luiz Fernando. Dialysis as a Treatment Option for a Patient With Normal Kidney Function and Familial Tumoral Calcinosis Due to a Compound Heterozygous FGF23 Mutation. American journal of kidney diseases, v. 72, n. 3, p. 457-461, 2018Tradução . . Disponível em: https://doi.org/10.1053/j.ajkd.2017.12.020. Acesso em: 17 out. 2024.APA
Goldenstein, P. T., & Onuchic, L. F. (2018). Dialysis as a Treatment Option for a Patient With Normal Kidney Function and Familial Tumoral Calcinosis Due to a Compound Heterozygous FGF23 Mutation. American journal of kidney diseases, 72( 3), 457-461. doi:10.1053/j.ajkd.2017.12.020NLM
Goldenstein PT, Onuchic LF. Dialysis as a Treatment Option for a Patient With Normal Kidney Function and Familial Tumoral Calcinosis Due to a Compound Heterozygous FGF23 Mutation [Internet]. American journal of kidney diseases. 2018 ; 72( 3): 457-461.[citado 2024 out. 17 ] Available from: https://doi.org/10.1053/j.ajkd.2017.12.020Vancouver
Goldenstein PT, Onuchic LF. Dialysis as a Treatment Option for a Patient With Normal Kidney Function and Familial Tumoral Calcinosis Due to a Compound Heterozygous FGF23 Mutation [Internet]. American journal of kidney diseases. 2018 ; 72( 3): 457-461.[citado 2024 out. 17 ] Available from: https://doi.org/10.1053/j.ajkd.2017.12.020
